What caused the decline in breast cancer mortality in the United Kingdom?

Breast Cancer

Volumn 11, Issue 2, 2004, Pages 156-159

  Kobayashi, Shunzo ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Breast screening; Mortality; United Kingdom

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; MASS SCREENING; MIDDLE AGED; MORBIDITY; MORTALITY; PATIENT EDUCATION; PUBLIC HEALTH; RETROSPECTIVE STUDY; SOCIAL STATUS; UNITED KINGDOM; UTILIZATION REVIEW;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GREAT BRITAIN; HUMANS; MASS SCREENING; MIDDLE AGED; MORBIDITY; MORTALITY; NATIONAL HEALTH PROGRAMS; NEOPLASM STAGING; PATIENT EDUCATION; RETROSPECTIVE STUDIES; SOCIAL CONDITIONS;

EID: 16544390708     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02968295     Document Type: Article

References (18)

1. Beral V, Hermon C, Reeves G, Peto PC Sudden fall in breast cancer death rates in England and Wales. Lancet 24:1642-1643, 1995.
2. Peto R, Boreham J, Clarke M, Davies C, Veral V: UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355:1822, 2000. (Pubitemid 30265099)
3. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: Comparison of observed with predicted mortality. Br MedJ 16:665-669, 2000.
4. Nystrom L, Andersson I, Bjurstman N, Frisell J, Nordenskjold B, Rutqvist LE: Long-term effects of mammography screening: Updated overview of the Swedish randomized trials. Lancet 359:909-919, 2002. (Pubitemid 34246378)
5. Ueda K, Tsukuma H, Tanaka H, Ajiki W, Oshima A: Estimation of individualized probabilities of developing breast cancer for Japanese women. Breast Cancer 10:54-62, 2003.
6. Bray F, Sankila R, Ferlay J, Parkin DM: Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99-166, 2002. (Pubitemid 34031832)
7. Personal information from Mr. Nicola Cooper, a Senior Cancer Epidemiologist, National Cancer Intelligence Centre, Office for National Statistics, UK.
8. NHS Breast Screening Programme: Annual Review 1999 (from ref. 8).
9. (No authors sited): Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organization. Lancet 1:836-840, 1985.
10. Ribeiro G, Swindell R: The Christie Hospital tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma-7 year results. Eur J Cancer Clin Oncol 21:897-900, 1985. (Pubitemid 15003369)
11. (No authors sited): Adjuvant tamoxifen in the management of operable breast cancer: The Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet 2:171-175, 1987.
12. Singh L, Wilson AJ, Baum M, Whimster WF, Birch IH, Jackson IM, Lowrey C, Palmer MK: The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO (Nolvadex) trial. Br J Cancer 57:612-614, 1988.
13. Ribeiro G, Swindell Pc The Christie hospital adjuvant tamoxifen trial-status at 10 years. Br J Cancer 57:601-603, 1988.
14. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Rabb PJ: Effect of NHS Breast Cancer Screening Programme on Mortality from Breast Cancer in England and Wales, 1990-8: Comparison of Observed with Predicted Mortality. Br Med J16:665-669, 2000.
15. International Agency for Research for Cancer (IARC): Handbooks on Cancer Prevention, volume 7: Breast Cancer Screening, IARC, Lyons, 2002.
16. NHS Breast Screening Programme: Annual Review 2001. Informing choice in breast screening (from ref. 8).
17. Nystrom L, Andersso I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE: Long-term effects of mammography screening: Updated overview of the Swedish randomized trials. Lancet 359:909-919, 2002. (Pubitemid 34246378)
18. Otto SJ, Fracheboud J, Looman CW, Broeders M J, Boer R, Hendriks JH, Verbek AL, de Koning HJ, National Evaluation Team for Breast Screening: Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: A systemic review. Lancet 361:1411-1417, 2003. (Pubitemid 36515040)